RecruitingNot ApplicableNCT06685016

Evaluation of Dental and Periodontal Health After IPR in Patients in Orthodontic Treatment With Clear Aligners

Evaluation of Dental and Periodontal Health After Interproximal Enamel Reduction, in Patients in Orthodontic Treatment With Clear Aligners, and Comparison Between Laser Diode and Sodium Fluoride for the Treatment of Dentin Hypersensitivity


Sponsor

University of Campania Luigi Vanvitelli

Enrollment

30 participants

Start Date

Jun 24, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study aimed to evaluate dental and periodontal health after interproximal enamel reduction and to compare Laser diode (a device used in the Orthodontic Program) and sodium fluoride (often used in the Orthodontic Program and in the Material Dental Program). The hypothesis was that the intervention groups would show a lower dentin hypersensitivity incidence than the control group during orthodontic treatment.


Eligibility

Min Age: 17 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Evaluation of Dentin hypersensitivity with VAS scale for people with bleeding gum, plaque, dental, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 17 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTEvaluation of Dentin hypersensitivity with VAS scale

Dentin hypersensitivity and periodontal indices evaluation are performed after and before IPR, at 1 week, 1 month and 3 months


Locations(1)

Multidisciplinary department of Medical-Surgical and Dental Specialties

Naples, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06685016


Related Trials